OraSure Technologies Joins With Actress/Model Dayana Mendoza and the Latino
Commission on AIDS to Promote the OraQuick(R) In-Home HIV Test for National
Latino AIDS Awareness Day
OraQuick^® In-Home HIV Test Now Available in Retail Stores Nationwide
Press Conference at New York City Hall Monday, October 15 @ 10:00 AM
BETHLEHEM, Pa., Oct. 15, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR) today announced that it will join with actress/model and former
Miss Universe Dayana Mendoza and the Latino Commission on AIDS to promote the
OraQuick^® In-Home HIV test and the importance of knowing your HIV status for
National Latino AIDS Awareness Day, taking place on October 15, 2012.
National Latino AIDS Awareness Day (NLAAD) is a national community
mobilization campaign that was established in 2003 by the Latino Commission on
AIDS in response to the devastating impact of HIV and AIDS on Hispanic/Latino
communities nationwide. NLAAD unites the diverse Hispanic/Latino community in
an effort to raise HIV awareness and promote HIV testing, prevention and
OraSure recently announced the launch of its OraQuick® In-Home HIV Test, the
first rapid infectious disease test ever to be made available directly to
consumers for in-home use. As part of the launch, the Company is addressing a
major public health need by collaborating with Ms. Mendoza, as well as other
celebrities, in an ongoing educational campaign on the importance of knowing
your HIV status.
"HIV/AIDS is a significant health threat to Hispanic/Latino communities in the
United States," said Ms. Mendoza. "Knowing your status is the best thing, no
matter who you are. The good news is that there's now a new way to learn your
status and help prevent the spread of HIV. The FDA recently approved OraQuick,
the first in-home oral rapid HIV test. OraQuick allows you to test for HIV in
the comfort and privacy of your home, with results in just 20 minutes."
"The new OraQuick® In-Home HIV Test is a critical new tool in addressing the
impact of HIV/AIDS in our communities," said Guillermo Chacón, President of
the Latino Commission on AIDS. "This test will help to reduce stigma and fill
an unmet need by providing an additional testing option for individuals who
otherwise might not get tested."
"We are honored to be working with Ms. Dayana Mendoza, the Latino Commission
on AIDS, and so many dedicated state and local organizations to raise
awareness of the importance of HIV testing on National Latino AIDS Awareness
Day," said Douglas A. Michels, President and Chief Executive Officer of
OraSure Technologies. "Now for the first time ever, individuals have access to
the OraQuick In-Home HIV test – the same test healthcare professionals have
used and trusted for years – that will empower them to learn their HIV status
in the comfort and privacy of their own homes."
Despite testing options that have been available for years, the Centers for
Disease Control and Prevention (CDC) estimate that approximately 1.2 million
people in the U.S. have HIV and approximately 240,000 of them are unaware of
their status. Those who do not know they are HIV positive are
disproportionately responsible for a majority of the 50,000 new HIV infections
that occur each year. The CDC recommends routine HIV screening for all people
ages 13 to 64, with more frequent testing for people at higher risk.
The OraQuick® In-Home HIV Test detects antibodies to both HIV-1 and HIV-2 with
an oral swab, providing a confidential in-home testing option with results in
as little as 20 minutes. The in-home test is an over-the-counter version of
OraQuick ADVANCE^®, an oral swab rapid test with more than 25 million units
sold in the professional market, including doctors, hospitals, clinics and
other trained professionals. The OraQuick In-Home HIV Test is now available in
retail stores nationwide, through select retailers online and at OraQuick.com.
NLAAD Press Conference Information:
In recognition of National Latino AIDS Awareness Day, The Latino Commission on
AIDS will hold a press conference on Monday, October 15^th at 10:00 AM on the
steps of New York City Hall.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and testing solutions for detecting various drugs
of abuse. In July 2012, the Company received approval from the U.S. Food and
Drug Administration for the Company's OraQuick® In-Home HIV Test for sale
directly to consumers in the over-the-counter (OTC) market – making it the
first and only rapid OTC HIV test approved in the U.S. In addition, the
Company is a leading provider of oral fluid sample collection, stabilization
and preparation products for molecular diagnostic applications. OraSure's
portfolio of products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors, government
agencies, physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical information
to patients, empowering them to make decisions to improve and protect their
For more information on OraSure Technologies, please visit www.orasure.com.
The OraSure Technologies, Inc. logo is available at
CONTACT: Media Contact:
Zer0 to 5ive for OraSure Technologies
Press spacebar to pause and continue. Press esc to stop.